UroToday

ASTRO 2025: Conventional vs. Hypofractionated, Radiotherapy for High-Risk Prostate Cancer: 10-Year Outcomes of the Randomized, Non-Inferiority, Phase 3 PCS5 Trial

These 10-year results confirm that hypofractionated radiotherapy (68 Gy in 25 fractions) is non-inferior to conventionally fractionated radiotherapy (76 Gy in 38 fractions) for high-risk prostate ...

Randomized study comparing proton and photon radiation for breast cancer finds both preserve quality of life

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report ...
Business Wire

First Randomized Controlled Trial Comparing Woebot to Clinician-Led Psychotherapy Reveals Digital Mental Health Intervention Is Non-Inferior in Reducing Depressive Symptoms ...

NEW YORK--(BUSINESS WIRE)--Woebot Health today announced positive results from a study at Children’s Hospital of The King’s Daughters (CHKD) showing that the digital mental health intervention W-GenZD ...
ascopubs.org

Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES ...

Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled Trial A total ...